TD ASSET MANAGEMENT INC - IMMUNOMEDICS INC ownership

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q2 2020$4,644,000
+251.0%
131,045
+33.5%
0.01%
+250.0%
Q1 2020$1,323,000
-43.6%
98,125
-11.5%
0.00%
-33.3%
Q4 2019$2,345,000
+33.2%
110,825
-16.6%
0.00%0.0%
Q3 2019$1,761,000
+0.9%
132,812
+5.6%
0.00%0.0%
Q2 2019$1,745,000
-56.8%
125,812
-40.2%
0.00%
-50.0%
Q1 2019$4,038,000
-7.0%
210,218
-30.9%
0.01%
-25.0%
Q4 2018$4,342,000
-32.9%
304,288
-2.1%
0.01%
-20.0%
Q3 2018$6,474,000
+27.2%
310,788
+44.5%
0.01%
+25.0%
Q2 2018$5,091,000
+104.0%
215,088
+25.9%
0.01%
+100.0%
Q1 2018$2,495,000
-2.7%
170,800
+7.7%
0.00%0.0%
Q4 2017$2,563,000
+18.6%
158,600
+2.6%
0.00%
+33.3%
Q3 2017$2,161,000
+62.7%
154,600
+2.8%
0.00%
+50.0%
Q2 2017$1,328,000
+55.3%
150,400
+13.8%
0.00%
+100.0%
Q1 2017$855,000132,2000.00%
Other shareholders

There were no reported owners of IMMUNOMEDICS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of IMMUNOMEDICS INC shareholders